Nuclear medicine plays a major role in the areas of oncology, cardiology, and neurology for diagnosis as well as in treatment planning, the note explained.
MedGenome, a genomics diagnostics and research services company, has made a majority investment in Mumbai’s Medcare Management Services – a radiology and nuclear medicine provider, for an undisclosed sum.
Medcare has four fully integrated imaging facilities at Chembur, Goregaon, Andheri and Navi Mumbai. The company offers advanced imaging services, including PET-CT, CT, Mammography, Nuclear Medicine Scans, and theragnostic facilities. It was founded in 2012 by Atul Marwah, a nuclear medicine expert with decades of experience in establishing and leading nuclear medicine departments at Mumbai’s top hospitals, and Ruchira Marwah, a seasoned radiologist, the note said.
Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, and Chairman of the Board of MedGenome, said, MedGenome’s investment in Medcare marked an important step in building an integrated diagnostics ecosystem for India. Surajit Chakrabartty, MedGenome Chief Financial Officer added, integrating Medcare with MedGenome further strengthened their presence in western India and aligned with their long-term vision of building a unified, integrated diagnostics ecosystem.
Major role
Nuclear medicine plays a major role in the areas of oncology, cardiology, and neurology for diagnosis as well as in treatment planning, the note explained. PET-CT Imaging, complemented with genetic tests, enables early cancer detection and has a significant impact on the course of treatment and monitoring, delivering enhanced patient outcomes, it added.
Atul Marwah, Founder -Medcare, said, along with MedGenome, Medcare could unlock significant growth opportunities, enabling them to offer integrated imaging, pathology, and genomics solutions, which are especially critical in oncology and the management of complex diseases.
Published on March 2, 2026